Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes

A. Lladó, P. Mannucci, A. F. Carpentier, S. Paris, Y. Blanco, A. Saiz, J. Y. Delattre, F. Graus

Research output: Contribution to journalArticlepeer-review

Abstract

The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.

Original languageEnglish
Pages (from-to)1947-1949
Number of pages3
JournalNeurology
Volume63
Issue number10
Publication statusPublished - Nov 23 2004

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes'. Together they form a unique fingerprint.

Cite this